[Urogenital disorders in elderly patients].
Nakayama
Hidetoshi
H
Ogura
Haruyuki
H
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001918:Brachytherapy / Q000379:methods; D002561:Cerebrovascular Disorders / Q000150:complications; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D007564:Japan / Q000453:epidemiology; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D014549:Urinary Incontinence / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D014563:Urodynamics; D013520:Urologic Surgical Procedures
D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists; D015415:Biomarkers; D018680:Cholinergic Antagonists; D007457:Iodine Radioisotopes; D017430:Prostate-Specific Antigen